clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Rozynek E et al. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children. 2002 Acta Microbiol. Pol. pmid:12588100
Kondoh K et al. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa. 1996 Acta Otolaryngol Suppl pmid:8908271
Kozan G et al. Effect of systemic clarithromycin and prednisolone on histamine-induced otitis media in guinea pigs. 2015 Acta Otolaryngol. pmid:26143935
Iino Y et al. Clinical effects of clarithromycin on persistent inflammation following Haemophilus influenzae-positive acute otitis media. 2015 Acta Otolaryngol. pmid:25649881
Cantarella G et al. Outcomes of structural fat grafting for paralytic and non-paralytic dysphonia. 2011 Acta Otorhinolaryngol Ital pmid:22064781
Piédrola Maroto D et al. [Present situation of antibiotic resistances in tonsillar infections]. 2006 Acta Otorrinolaringol Esp pmid:16686226
Cadranel S et al. Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy. 2007 Acta Paediatr. pmid:17187610
de Jong J et al. Antibiotic usage, dosage and course length in children between 0 and 4 years. 2009 Acta Paediatr. pmid:19397542
Main KM et al. Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient. 2002 Acta Paediatr. pmid:12412882
Hurduc V et al. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. 2009 Acta Paediatr. pmid:18681892
Hu YY et al. Antimicrobial susceptibility of Haemophilus influenzae among children in Beijing, China, 1999-2000. 2002 Acta Paediatr. pmid:11951998
Forslöw U et al. Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. 2003 Acta Paediatr. pmid:12948065
Germanakis I et al. Clarithromycin treatment and QT prolongation in childhood. 2006 Acta Paediatr. pmid:17129988
Lerro P et al. CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children. 2000 Acta Paediatr. pmid:11106041
Tirén U et al. Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. 1999 Acta Paediatr. pmid:10102149
König C et al. Legionella waltersii--a novel cause of pneumonia? 2005 Acta Paediatr. pmid:16299887
Luo X et al. Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism. 2009 Acta Pharmacol. Sin. pmid:19701237
Cao S et al. Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy. 2012 Acta Pharmacol. Sin. pmid:22820908
Qiao AM et al. Involvement of mitochondria and caspase pathways in N-demethyl-clarithromycin-induced apoptosis in human cervical cancer HeLa cell. 2006 Acta Pharmacol. Sin. pmid:17112418
Zhang L et al. P-glycoprotein restricted transport of nimodipine across blood-brain barrier. 2003 Acta Pharmacol. Sin. pmid:12956939
UÄŸurlu T et al. Optimization and evaluation of clarithromycin floating tablets using experimental mixture design. 2014 Mar-Apr Acta Pol Pharm pmid:25272652
Ozkan Y et al. Clarithromycin targeting to lung: optimization of the size, morphology and release characteristics of albumin microspheres. 2000 Sep-Oct Acta Pol Pharm pmid:11126029
Patel SS et al. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori. 2006 Jan-Feb Acta Pol Pharm pmid:17515330
Baranowski WJ Clarithromycin-induced hypomania in a child - a case report. 2010 Acta Psychiatr Scand pmid:20491717
Cameselle D et al. [Sporotrichoid cutaneous infection by Mycobacterium haemophilum in an AIDS patient]. 2007 Actas Dermosifiliogr pmid:17504704
Gutiérrez-de la Peña J et al. [Three cases of panniculitis due to Mycobacterium abscessus after mesotherapy]. 2010 Actas Dermosifiliogr pmid:20223169
Iwańczak BM et al. Assessment of Sequential and Standard Triple Therapy in Treatment of Helicobacter pylori Infection in Children Dependent on Bacteria Sensitivity to Antibiotics. Adv Clin Exp Med pmid:27629844
Gościniak G et al. Frequency of infection with Helicobacter pylori isolates of different antimicrobial profiles in children and adolescents: A preliminary study. Adv Clin Exp Med pmid:28791844
Radzikowska E et al. Clarithromycin Decreases IL-6 Concentration in Serum and BAL Fluid in Patients with Cryptogenic Organizing Pneumonia. Adv Clin Exp Med pmid:28028949
Tuchman SA et al. Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. 2012 Adv Hematol pmid:22690220
Blackington E The gastric demon. An update on Helicobacter pylori infection. 1999 Adv Nurse Pract pmid:10745720
Suleymanlar I et al. Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients. 1999 Adv Perit Dial pmid:10682076
Cheng KS et al. Serum IL-8 as a possible marker for determining the status of Helicobacter pylori infection in patients with untreated and treated peptic ulcer. 2004 Jan-Feb Adv Ther pmid:15191156
McCarty J et al. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. 2000 Jan-Feb Adv Ther pmid:10915400
MacLeod CM et al. Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. 2001 Mar-Apr Adv Ther pmid:11446271
Martinot JB et al. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis. 2001 Jan-Feb Adv Ther pmid:11512528
Sakurai Y et al. Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study. 2016 Adv Ther pmid:27432383
Nightingale CH A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel. 2000 May-Jun Adv Ther pmid:11183454
Zycinska K et al. Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. 2016 Adv. Exp. Med. Biol. pmid:27620311
Siekmeier R et al. Inhalation of macrolides: a novel approach to treatment of pulmonary infections. 2015 Adv. Exp. Med. Biol. pmid:25252902
Radzikowska E et al. Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. 2016 Adv. Exp. Med. Biol. pmid:26987326
Rodrigues AD and Wong SL Application of human liver microsomes in metabolism-based drug-drug interactions: in vitro-in vivo correlations and the Abbott Laboratories experience. 1997 Adv. Pharmacol. pmid:9342173
Chang CH et al. Non-Tuberculous Mycobacteria Infection Following Autologous Fat Grafting on the Face. 2017 Aesthet Surg J pmid:29045552
Pereira LH and Sterodimas A Autologous fat transplantation and delayed silicone implant insertion in a case of Mycobacterium avium breast infection. 2010 Aesthetic Plast Surg pmid:19495858
Aboderin OA et al. Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria. 2007 Afr Health Sci pmid:18052867
Ndip RN et al. In-vitro antimicrobial activity of selected honeys on clinical isolates of Helicobacter pylori. 2007 Afr Health Sci pmid:21499488
Fichtenbaum CJ et al. Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman. 2001 AIDS pmid:11546956
Holmberg SD and Moorman AC Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis. 2001 AIDS pmid:11504998
Hewitt RG et al. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. 1999 AIDS pmid:10449290
Fichtenbaum CJ et al. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. 2000 AIDS pmid:11153670